CHINESE ACADEMY OF SCIENCES;GUANGZHOU INSTITUTE OF BIOMEDICINE AND HEALTH
发明人:
DING, KE,WONG, CHIWAI,PENG, LIJIE,KANG, ZHANFANG,ZHOU, XI
申请号：
EP09797343
公开号：
EP2314588A4
申请日:
2009.03.06
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The compounds according to formula (I), their pharmaceutically acceptable acid or base addition salts, and the uses thereof. These compounds and their pharmaceutically acceptable acid or base addition salts can be used for preparing medicaments for modulating estrogen related receptors (ERR), and treating metabolic diseases, such as high blood fat, fatty liver, hyperglycemia, diabetes, obesity. The substituents of the formula are defined in the description.
